Plain-English translation of NCT07404852 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study tests a treatment called transcutaneous auricular vagus nerve stimulation (taVNS)—a non-invasive device that delivers gentle electrical stimulation to a nerve in your ear. Researchers believe this stimulation can help calm your body's inflammatory response after a stroke, potentially reducing brain damage and improving recovery. The treatment is quick to apply and can be started immediately in the hospital right after your stroke.
After a stroke caused by a blocked blood vessel, your brain can suffer additional damage from inflammation and swelling—even after the blockage is cleared. Current treatments don't fully prevent this secondary injury, and many stroke patients still face significant long-term disability. This trial is testing whether the treatment can activate your body's natural anti-inflammatory systems to better protect your brain during the critical hours and days after stroke.
You likely qualify if…
You likely don't qualify if…
If you enroll, researchers will attach a small electrode to your ear and you'll receive either real or sham (pretend) stimulation sessions—20 minutes, twice daily while you're in the hospital. You won't know which group you're in; this helps doctors fairly compare results. Blood tests will measure inflammation levels, and your recovery will be tracked to see if the treatment helps.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States